Document Detail


Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
MedLine Citation:
PMID:  13680550     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Decreased heart rate recovery (HRR) is a predictor of mortality in patients with coronary artery disease and preserved left ventricular function. We investigated the changes in HRR and assessed the impact of beta-blockade therapy on these parameters in patients with symptomatic congestive heart failure (CHF). METHODS AND RESULTS: HRR, defined as the difference from peak exercise heart rate (HR) to HR measured at 1, 2, and 3 minutes after maximal exercise test, was studied in 23 stable CHF patients and 12 healthy subjects. Patients with CHF performed a maximal exercise test using a Ramp protocol before and after 6 months of therapy with either metoprolol or carvedilol. Patients with CHF exhibited a significantly attenuated HRR compared with healthy subjects at 1 minute (17.8 +/- 5.8 versus 26.8 +/- 16.2 beats), 2 minutes (34.0 +/- 10.6 versus 48.0 +/- 11.2 bpm) and 3 minutes (41.0 +/- 12.4 versus 60.0 +/-12.4 bpm) after exercise (P<.05 for all parameters). Beta-blocker therapy for 6 months did not significantly improve HRR. CONCLUSION: HRR is markedly attenuated in stable CHF patients compared with healthy subjects. Long-term beta-blocker therapy appears to cause no significant improvement in HRR up to 3 minutes after maximal exercise.
Authors:
Normand Racine; Martine Blanchet; Anique Ducharme; Johanne Marquis; Jean-Marc Boucher; Martin Juneau; Michel White
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  9     ISSN:  1071-9164     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-09-18     Completed Date:  2004-03-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  296-302     Citation Subset:  IM    
Affiliation:
Department of Medicine, Montreal Heart Institute, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Adult
Aged
Blood Pressure / drug effects,  physiology
Carbazoles / therapeutic use
Diastole / drug effects,  physiology
Exercise / physiology*
Exercise Test
Female
Heart Failure / drug therapy,  physiopathology*
Heart Rate / drug effects,  physiology*
Humans
Male
Metoprolol / therapeutic use
Middle Aged
Oxygen Consumption / drug effects,  physiology
Predictive Value of Tests
Propanolamines / therapeutic use
Recovery of Function / drug effects,  physiology*
Stroke Volume / drug effects,  physiology
Systole / drug effects,  physiology
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 37350-58-6/Metoprolol; 72956-09-3/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exercise training improves insulin stimulated skeletal muscle glucose uptake independent of changes ...
Next Document:  In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic...